Drug
Dasotraline clinical trials
Also written SEP-225289.
- studies test it
- 13
- open now
- 0
- in phase 3
- 9
- first study started
- 2007
How studies write it
Studies that test it under each name
Development codes
Studies by the year they started
13 studies that test it; most in 2014 (3)
| Year | Studies |
|---|---|
| 2007 | 1 |
| 2012 | 1 |
| 2014 | 3 |
| 2015 | 3 |
| 2016 | 3 |
| 2017 | 2 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 2
- Phase 2
- 4
- Phase 3
- 9
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 13 · Other 0
Studies
Open first, then newest update. How each study uses dasotraline is read from its arms, and is right about nine times in ten.
Testing it · 13
- Dasotraline Pediatric ADHD StudyCompletedPhase 2/3Sumitomo Pharma America, Inc.NCT02428088Written as Dasotraline
- Dasotraline Binge Eating Disorder Extension StudyCompletedPhase 3Sumitomo Pharma America, Inc.NCT02684279Written as Dasotraline
- A Study to Evaluate a Drug (Dasotraline) on the Safety, Effectiveness and How Well the Body Tolerates it, in Adults With Moderate to Severe Binge Eating DisorderCompletedPhase 3Sumitomo Pharma America, Inc.NCT03107026Written as dasotraline 4mg
- A Study to Evaluate the Efficacy and Safety of Dasotraline in Children 6 to 12 Years Old With Attention-Deficit Hyperactivity Disorder (ADHD) in a Simulated Classroom Setting.CompletedPhase 3Sumitomo Pharma America, Inc.NCT03231800Written as dasotraline
- A Study to Evaluate the Efficacy and Safety of Dasotraline in Children 6 to 12 Years of Age With Attention-Deficit Hyperactivity Disorder (ADHD) in a Simulated Classroom Setting.CompletedPhase 3Sumitomo Pharma America, Inc.NCT02734693Written as dasotraline 4mg
- Dasotraline Pediatric Extension StudyCompletedPhase 3Sumitomo Pharma America, Inc.NCT02457819Written as Dasotraline
- Dasotraline Binge Eating Disorder StudyCompletedPhase 2/3Sumitomo Pharma America, Inc.NCT02564588Written as Dasotraline
- Dasotraline Adult ADHD StudyCompletedPhase 3Sumitomo Pharma America, Inc.NCT02276209Written as Dasotraline
- Open-label Safety Study in Adults With ADHDCompletedPhase 3Sumitomo Pharma America, Inc.NCT02160262Written as Dasotraline
- Study of the What the Body Does to the Drug in Subjects With Mild, Moderate, and Severe Liver DysfunctionCompletedPhase 1Sumitomo Pharma America, Inc.NCT02795637Written as dasotraline
- Dasotraline SEP360-105 Pediatric PK/PD StudyCompletedPhase 1Sumitomo Pharma America, Inc.NCT02195167Written as Dasotraline 1 mg, 2 mg, 4 mg, 8 mg, 12 mg, 16 mg, 20 mg, 24 mg, 28 mg, 32 mg once daily
- Adult Attention Deficit Hyperactivity DisorderCompletedPhase 2Sumitomo Pharma America, Inc.NCT01692782Written as SEP-225289
- A Safety, Efficacy and Tolerability Study of SEP-225289CompletedPhase 2Sumitomo Pharma America, Inc.NCT00584974Written as SEP-225289
Codes
What other systems call dasotraline · ClinicalTrials.gg INT000501
- UNII (FDA) 4D28EY0L5TDASOTRALINEConfirmed FDA, NLM, Wikidata
- Wikidata Q27076989dasotralineConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C166750DasotralineOne source FDA
- DrugBank DB12305One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | 4D28EY0L5T | DASOTRALINE | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q27076989 | dasotraline | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C166750 | Dasotraline | One source FDA |
| DrugBank | DB12305 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.